Langar Global HealthTech ETF (LGHT) has seen unusual trading volume, which is 24× higher than its average daily volume.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Among its largest holdings, Resmed Inc and Dexcom are in focus as both prepare to report upcoming quarterly earnings, with analysts expecting solid revenue and maintaining generally bullish ratings and upside price targets. Moderna is drawing attention after Goldman Sachs and Bernstein reiterated Hold ratings and price targets that imply potential downside from current levels, underscoring ongoing caution around the stock. Zimmer Biomet is also in the spotlight after the surprise departure of its CFO unsettled investors even as the company reported better‑than‑expected revenue, raised its earnings and free‑cash‑flow guidance, and reaffirmed its full‑year revenue outlook, highlighting a mix of leadership risk and operational strength within the ETF’s portfolio.